Ahmet Can Berkyurek
About Ahmet Can Berkyurek
Ahmet Can Berkyurek is the Founder and CEO of Cambridge Medixine Ltd. since 2023 and has held various significant roles in research and development, including positions at UCL, University of Cambridge, and VaxEquity Ltd.
Current Role at Cambridge Medixine Ltd
Ahmet Can Berkyurek serves as the Founder and CEO of Cambridge Medixine Ltd, a position he has held since 2023. In this role, he focuses on advancing the company's mission within the healthcare sector. His leadership is directed towards fostering innovation and developing solutions that address current medical challenges.
Work at ZINC
Berkyurek has been working at ZINC as Founder In Residence since 2024. In this capacity, he engages with early-stage companies, contributing his expertise to initiatives aimed at improving health and environmental sustainability. His involvement in ZINC reflects his commitment to fostering innovation in the biotech sector.
Educational Background
Berkyurek holds a Bachelor's degree in Molecular Biology from Istanbul Technical University, which he completed from 2005 to 2009. He furthered his education at Osaka University, earning a Master of Science in Biochemistry and Molecular Biology from 2010 to 2012, followed by a Doctor of Philosophy in the same field from 2012 to 2015. Additionally, he studied Research Methodology and Quantitative Methods at Universidad de Celaya, A.C., obtaining a Bachelor's degree from 2004 to 2005.
Professional Experience in Research
Berkyurek has extensive experience in the field of molecular biology and RNA development. He worked as a Postdoctoral Researcher at the University of Cambridge from 2015 to 2020, where he enhanced his research expertise. He also held positions as a Senior Scientist at VaxEquity Ltd from 2022 to 2023 and at Eleven Therapeutics from 2021 to 2022, focusing on RNA development and contributing to significant research projects.
Leadership Role at UCL
Before his current roles, Berkyurek held a leadership position as Junior Group Leader at University College London (UCL) from 2020 to 2021. His responsibilities included overseeing research initiatives and contributing to the academic community in London. This role followed his earlier work at UCL, where he developed his leadership and research skills.